novartis ag pandemic flu vaccine takes step in europe the european union health regulator recommended approval of an experimental pandemic flu vaccine from novartis ag focetria is intended to prevent flu during a pandemic such as if the hn bird flu virus mutated into a strain that could pass easily from person to person the committee for medicinal products for human use backed a "mock up" type of focetria once a pandemic strain is identified that could be replaced with the pandemic version without starting the regulatory process from scratch 
